AAVE’s discussion volume doubled overnight. The apparent reason is that the price rose nearly 20% over seven days, but what’s really being rehashed is its identity as collateral.
Some say that a certain collateral infrastructure had a security incident, and the relevant parties have proactively exited the validators. Aave, meanwhile, says its products have no exposure—but this claim still lacks a complete technical path to verify.
Another thread is more direct: several on-chain observers noted that over a four-hour window, open interest on a single line increased by 3% to 7%. The long side makes up about 65%, yet the price has been repeatedly grinding between 166 and 170. Funding rates are only around 0.005%. Bulls think big money hasn’t left, while bears say it’s fuel being gathered for the shorts.
These two lines are actually one thing: the market is re-pricing how much of a discount collateral in DeFi lending should receive—and how much leverage should be kept.
If, in the end, it turns out to be an operational incident that didn’t harm principal, does this seven-day surge really deserve to be treated as revenue-based pricing?
Some say that a certain collateral infrastructure had a security incident, and the relevant parties have proactively exited the validators. Aave, meanwhile, says its products have no exposure—but this claim still lacks a complete technical path to verify.
Another thread is more direct: several on-chain observers noted that over a four-hour window, open interest on a single line increased by 3% to 7%. The long side makes up about 65%, yet the price has been repeatedly grinding between 166 and 170. Funding rates are only around 0.005%. Bulls think big money hasn’t left, while bears say it’s fuel being gathered for the shorts.
These two lines are actually one thing: the market is re-pricing how much of a discount collateral in DeFi lending should receive—and how much leverage should be kept.
If, in the end, it turns out to be an operational incident that didn’t harm principal, does this seven-day surge really deserve to be treated as revenue-based pricing?